Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 6
2004 5
2005 8
2006 7
2007 10
2008 9
2009 21
2010 9
2011 12
2012 5
2013 3
2014 5
2015 5
2016 4
2017 3
2018 5
2019 3
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20832548

118 results
Results by year
Filters applied: . Clear all
Page 1
Sirolimus in liver transplant recipients: a large single-center experience.
Vivarelli M, Dazzi A, Cucchetti A, Gasbarrini A, Zanello M, Di Gioia P, Bianchi G, Tamè MR, Gaudio MD, Ravaioli M, Cescon M, Grazi GL, Pinna AD. Vivarelli M, et al. Transplant Proc. 2010 Sep;42(7):2579-84. doi: 10.1016/j.transproceed.2010.04.045. Transplant Proc. 2010. PMID: 20832548
Sirolimus therapy in liver transplant patients: an initial experience at a single center.
Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U. Nocera A, et al. Transplant Proc. 2008 Jul-Aug;40(6):1950-2. doi: 10.1016/j.transproceed.2008.05.005. Transplant Proc. 2008. PMID: 18675098
Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W, Wang D, Ling X, Kao AA, Kong Y, Shang Y, Guo Z, He X. Liang W, et al. Liver Transpl. 2012 Jan;18(1):62-9. doi: 10.1002/lt.22441. Liver Transpl. 2012. PMID: 21964956 Free article.
Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence.
Castroagudín JF, Molina E, Tomé S, Otero E, Rodríguez M, Varo E. Castroagudín JF, et al. Transplant Proc. 2009 Apr;41(3):1003-4. doi: 10.1016/j.transproceed.2009.02.017. Transplant Proc. 2009. PMID: 19376410
Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J. Zhou J, et al. Transplant Proc. 2008 Dec;40(10):3548-53. doi: 10.1016/j.transproceed.2008.03.165. Transplant Proc. 2008. PMID: 19100435
Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q. Yang YJ, et al. Transplant Proc. 2008 Jun;40(5):1541-4. doi: 10.1016/j.transproceed.2008.01.081. Transplant Proc. 2008. PMID: 18589147
Early sirolimus therapy in renal transplant recipients at high risk: is it justified?
Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR. Halim MA, et al. Transplant Proc. 2009 Sep;41(7):2784-8. doi: 10.1016/j.transproceed.2009.07.015. Transplant Proc. 2009. PMID: 19765435
Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ. Sundberg AK, et al. Clin Transplant. 2004;18 Suppl 12:61-6. doi: 10.1111/j.1399-0012.2004.00220.x. Clin Transplant. 2004. PMID: 15217410
Indications and management of everolimus after liver transplantation.
Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R. Bilbao I, et al. Transplant Proc. 2009 Jul-Aug;41(6):2172-6. doi: 10.1016/j.transproceed.2009.06.087. Transplant Proc. 2009. PMID: 19715864
Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.
Shenoy S, Hardinger KL, Crippin J, Desai N, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W. Shenoy S, et al. Transplantation. 2007 May 27;83(10):1389-92. doi: 10.1097/01.tp.0000261630.63550.41. Transplantation. 2007. PMID: 17519792 Clinical Trial.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback